Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A Phase 3b, Open-Label, Single-Arm, Rollover Study to Evaluate Long-Term Safety in Subjects who have participated in other Luspatercept (ACE-536) Clinical Trials
Kaplan, Zane
(Primary Chief Investigator (PCI))
Medicine Monash Health
Australian Centre for Blood Diseases
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
1/11/19
→
31/10/24
View all
View less
Keywords
clinical trial
treatment efficacy
phase 3 study
thalassaemia